Ifosfamide and Vinorelbine in Advanced Platinum-Resistant Ovarian Cancer: Excessive Toxicity with a Potentially Active Regimen

By Gonzalez-Martn A.   Crespo C.   Garca-Lopez J.L.   Pedraza M.   Garrido P.   Lastra E.   Moyano A.  

Gynecologic Oncology, Vol. 84, Iss. 3, 2002-03 ,pp. : 368-373

Elsevier

Access to resources Recommend Favorite

Epothilones in the treatment of ovarian cancer

By Diaz-Padilla Ivan   Oza Amit M  

Future Oncology, Vol. 7, Iss. 4, 2011-04 ,pp. : 559-568

Future Medicine

Access to resources Recommend Favorite

Response and Toxicity to Topotecan in Sensitive Ovarian Cancer Cases with Small Residual Disease after First-Line Treatment with Carboplatinum and Paclitaxel

By Bolis G.   Scarfone G.   Tateo S.   Mangili G.   Villa A.   Parazzini F.  

Gynecologic Oncology, Vol. 80, Iss. 1, 2001-01 ,pp. : 13-15

Elsevier

Access to resources Recommend Favorite

Intraperitoneal chemotherapy for the treatment of ovarian cancer

By Dorff Tanya  

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 203-211

Informa Healthcare

Access to resources Recommend Favorite

Treatment Preferences in Recurrent Ovarian Cancer

By Donovan K.A.   Greene P.G.   Shuster J.L.   Partridge E.E.   Tucker D.C.  

Gynecologic Oncology, Vol. 86, Iss. 2, 2002-08 ,pp. : 200-211

Academic Press

Access to resources Recommend Favorite